Catheters Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Catheters Market Report Segments the Industry Into by Product (Cardiovascular Catheters, Urology Catheters, Intravenous Catheters, Neurovascular Catheters, Other Products), by End User (Hospitals, Long Term Care Facilities, Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, South America). Get Five Years of Historical Trends Plus Forecasts for the Next Five Years.

Global Catheters Market Size and Share

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Compare market size and growth of Global Catheters Market with other markets in Healthcare Industry

Global Catheters Market Analysis by Mordor Intelligence

The catheters market stood at USD 62.0 billion in 2025 and is forecast to reach USD 85.2 billion by 2030, advancing at a 6.6% CAGR. Demographic aging, a rising burden of chronic cardiovascular and renal disease, and broader acceptance of minimally invasive procedures continue to stimulate demand. Technology cycles that deliver smarter coatings, embedded sensors, and AI-aided designs further widen the clinical utility of catheter products. At the same time, supply-chain re-engineering for specialty polymers and silicone has become a strategic focus as manufacturers strive to maintain consistent quality and pricing. Competitive positioning pivots on innovation pipelines, as firms look to consolidate fragmented product niches and defend intellectual property. Opportunities remain strong in home-based self-care, where supportive reimbursement and telehealth services enable non-institutional treatment pathways, extending the addressable catheters market well beyond traditional hospital settings.

Key Report Takeaways

  • By product type, cardiovascular catheters led with 28.7% of catheters market share in 2024, whereas neurovascular catheters are projected to grow at a 7.3% CAGR through 2030. 
  • By end user, hospitals controlled 68.3% of the catheters market in 2024; home-care settings show the fastest expansion at a 7.5% CAGR to 2030. 
  • By application, cardiovascular procedures accounted for a 30.5% share of the catheters market size in 2024, while dialysis applications are set to advance at a 7.8% CAGR during the forecast period. 
  • By geography, North America held 43.3% of the catheters market in 2024, yet Asia-Pacific is on track to rise at an 8.3% CAGR through 2030.

Segment Analysis

By Product: Cardiovascular Leadership Amid Neurovascular Acceleration

Cardiovascular catheters delivered 28.7% of the catheters market in 2024, supported by entrenched clinical protocols across angiography, ablation, and electrophysiology. This maturity ensures stable volumes as hospitals routinely stock multiple sizes and configurations. The catheters market size for cardiovascular interventions is projected to widen at a steady clip in line with coronary disease prevalence. Neurovascular catheters, while still smaller by revenue, advance at a 7.3% CAGR as stroke centers expand and mechanical thrombectomy devices prove efficacy. Stanford’s milli-spinner technique posts 90% success versus 50% for legacy systems, underscoring technology-led upside.

Innovation pipelines remain active. Steerable tips, refined braiding, and softer polymers elevate neurovascular navigation, narrowing risk profiles and opening new procedural indications. Intravenous catheters stay the highest-volume consumable in hospital supply chains, but margin pressures persist given commoditized pricing. Specialty designs—ranging from occlusion balloons to drug-eluting configurations—command premium pricing and cushion profitability. Across categories, clinical evidence, reimbursement clarity, and material availability shape share shifts inside the broader catheters market.

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By End User: Hospital Dominance Challenged by Home-Care Growth

Hospitals represented 68.3% of 2024 sales, reflecting their central role in emergent and complex procedures that demand surgical suites and imaging infrastructure. This top position illustrates the catheters market size concentration within institutional care. However, home-care settings expand 7.5% annually as telehealth monitoring and simplified devices enable chronic-care patients to manage treatment without repeated admissions. The new 2026 HCPCS codes incentivize home-use devices, which could tilt procurement budgets toward community channels [3]Policy Brief, “2026 Home-Use Catheter Codes,” CMS, cms.gov.

Ambulatory surgical centers capture incremental share by performing routine catheter procedures in cost-controlled environments. Providers value fast patient turnaround and lower overhead compared with tertiary hospitals. Insurers steer appropriate cases to these facilities, ensuring sustained volume. Over the forecast horizon, end-user dynamics will hinge on the pace of care decentralization and on how swiftly payers adapt reimbursement frameworks, ultimately redefining sales channels for the catheters market.

By Application: Cardiovascular Procedures Lead, Dialysis Accelerates

Cardiovascular interventions accounted for 30.5% of the catheters market size in 2024, spanning angioplasty, structural heart, and electrophysiology. Clinical familiarity and robust evidence bases keep demand resilient, even amid cost-containment pressures. Dialysis access emerges fastest at 7.8% CAGR on the back of rising renal disease prevalence and expanded home dialysis programs. BD’s Pristine long-term hemodialysis catheter achieved 100% patency at 30 days and 91% at 180 days, signaling design improvements that enhance clinical confidence.

Urological applications maintain steady mid-single-digit growth fueled by aging populations and improved patient acceptance of intermittent catheterization. Complex neurovascular and structural cardiac uses, although smaller, provide outsized margin opportunities as sophisticated designs attract premium pricing. Application trends therefore diversify revenue streams and underline the multi-faceted demand drivers sustaining the catheters market.

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Geography Analysis

North America retained 43.3% of global revenue in 2024, underpinned by advanced hospital networks, early technology adoption, and favorable reimbursement. The FDA’s breakthrough-device pathway has quickened market entry for novel catheters, while Medicare coverage expansions offer tailwinds for high-value devices. Even so, mature-market price compression and hospital budget scrutiny put a ceiling on volume growth. Regulatory stability and predictable payment landscape still make the region a testing ground for premium catheter technologies, cementing its influence on the catheters market.

Europe stands as the second-largest cluster, shaped by the Medical Device Regulation. Stringent technical documentation and post-market surveillance raise compliance costs, especially for small firms, potentially consolidating supplier bases. Infection-prevention priorities and antimicrobial stewardship stimulate demand for coated and single-use devices. Brexit-related logistics challenges and shifts in public-tender rules, including moves to exclude certain foreign suppliers, complicate supply-chain planning yet may favor local manufacturing. The net impact is a cautious but quality-focused European catheters market.

Asia-Pacific is the fastest-growing theater, expanding at an 8.3% CAGR through 2030. Health-system modernization, rising surgical volumes, and government investment in universal care strengthen underlying demand. The region’s medical-technology spending is projected to hit USD 225 billion by 2030. Local manufacturing incentives, technology-transfer agreements, and a burgeoning private-hospital segment in India and Southeast Asia lower entry barriers. Nevertheless, heterogeneous regulatory regimes and price-cap policies require nuanced go-to-market strategies for firms seeking to scale in the APAC catheters market.

Catheters Market
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Competitive Landscape

The catheters market remains moderately fragmented, with multinational corporations and specialized developers jostling for share. Industry leaders exploit scale advantages in sterile manufacturing, distribution, and clinical education while pumping funds into R&D to maintain technological edges. Consolidation gathers pace: Stryker’s USD 4.9 billion acquisition of Inari Medical and BD’s USD 4.2 billion purchase of Edwards Lifesciences’ Critical Care division spotlight the premium assigned to innovation pipelines and therapeutic adjacencies.

Technology differentiation is a decisive lever. Players race to integrate antimicrobial coatings, embedded sensors, and AI-assisted modeling to deliver catheters that lower complication rates and enable real-time analytics. Teleflex’s plan to split into two pure-play companies—one focused on vascular access and interventional products—illustrates strategic sharpening around high-growth niches. Patent applications in catheter technologies have risen 25% each year, indicating intense efforts to lock in competitive moats.

Emerging companies seize white-space opportunities in neurovascular, dialysis, and home-care segments where incumbent product lines lag evolving clinical protocols. At the same time, polymer sourcing challenges and regulatory overheads push smaller outfits to seek contract-manufacturing alliances or become acquisition targets. Overall, sustained investment in material science, sensor fusion, and user-centric design will dictate the pecking order across the catheters market.

Global Catheters Industry Leaders

  1. Hollister

  2. Medtronic Plc

  3. Coloplast

  4. Becton, Dickinson and Company

  5. B. Braun Melsungen AG

  6. *Disclaimer: Major Players sorted in no particular order
Catheters Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • January 2025: B. Braun Medical introduced the Clik-FIX Epidural/Peripheral Nerve Block catheter securement device, aimed at reducing displacement during regional anesthesia.
  • January 2025: Radical Catheter Technologies secured FDA 510(k) clearance for its 8F neurovascular catheter built on proprietary ribbon technology.
  • January 2025: Sanford Health’s Dr. Bruce Gardner received FDA approval for a catheter design that auto-deflates its retention balloon when excessive tension occurs.
  • December 2024: Terumo Interventional Systems launched the R2P NaviCross peripheral support catheter in the US, featuring double-braided stainless-steel construction for enhanced torque control.

Table of Contents for Global Catheters Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising prevalence of cardiovascular, neurological & urological disorders
    • 4.2.2 Increasing uptake of minimally invasive interventions
    • 4.2.3 Surge in demand for antimicrobial & hydrophilic-coated catheters
    • 4.2.4 Rapid adoption of home-based self-catheterisation (under-reported)
    • 4.2.5 Integration of smart/connected sensor catheters for real-time monitoring (under-reported)
    • 4.2.6 Growth of ambulatory surgical centres in emerging markets (under-reported)
  • 4.3 Market Restraints
    • 4.3.1 Catheter-associated infections & biofilm formation
    • 4.3.2 Availability of non-catheter substitutes (e.g., drug pumps, stents)
    • 4.3.3 Polymer & silicone supply-chain volatility (under-reported)
    • 4.3.4 Reimbursement pressure in mature markets (under-reported)
  • 4.4 Value / Supply-Chain Analysis
  • 4.5 Regulatory Landscape
  • 4.6 Technological Outlook
  • 4.7 Porter’s Five Forces Analysis
    • 4.7.1 Threat of New Entrants
    • 4.7.2 Bargaining Power of Buyers
    • 4.7.3 Bargaining Power of Suppliers
    • 4.7.4 Threat of Substitutes
    • 4.7.5 Intensity of Competitive Rivalry

5. Market Size & Growth Forecasts (Value, USD)

  • 5.1 By Product
    • 5.1.1 Cardiovascular Catheters
    • 5.1.2 Urology Catheters
    • 5.1.3 Intravenous Catheters
    • 5.1.4 Neurovascular Catheters
    • 5.1.5 Specialty / Other Catheters
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Ambulatory Surgical Centres
    • 5.2.3 Home-care Settings
    • 5.2.4 Others
  • 5.3 By Application
    • 5.3.1 Cardiovascular Procedures
    • 5.3.2 Urinary Incontinence & Retention
    • 5.3.3 Dialysis & Renal Disorders
    • 5.3.4 Others
  • 5.4 By Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East & Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East & Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
    • 6.3.1 Abbott Laboratories
    • 6.3.2 B. Braun Melsungen AG
    • 6.3.3 Becton, Dickinson & Co. (C. R. Bard)
    • 6.3.4 Boston Scientific Corp.
    • 6.3.5 Coloplast A/S
    • 6.3.6 ConvaTec Group PLC
    • 6.3.7 Edwards Lifesciences Corp.
    • 6.3.8 Hollister Incorporated
    • 6.3.9 Johnson & Johnson (DePuy Synthes)
    • 6.3.10 Medtronic PLC
    • 6.3.11 Teleflex Inc.
    • 6.3.12 Terumo Corp.
    • 6.3.13 Biotronik SE & Co. KG
    • 6.3.14 Cook Medical
    • 6.3.15 Smiths Medical
    • 6.3.16 Cardinal Health
    • 6.3.17 Merit Medical Systems
    • 6.3.18 Penumbra Inc.
    • 6.3.19 AngioDynamics Inc.
    • 6.3.20 Amsino International

7. Market Opportunities & Future Outlook

  • 7.1 White-space & Unmet-Need Assessment
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Global Catheters Market Report Scope

As per the scope of the report, a catheter is a medical device that can be inserted into the body to treat diseases or perform surgical procedures. By modifying the material or adjusting the way catheters are manufactured, it is possible to tailor catheters for cardiovascular, urological, gastrointestinal, neurovascular, and ophthalmic applications. The Catheters Market is Segmented by Product (Cardiovascular Catheters, Urology Catheters, Intravenous Catheters, Neurovascular Catheters, and Other Products), End User (Hospitals, Long Term Care Facilities, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Product Cardiovascular Catheters
Urology Catheters
Intravenous Catheters
Neurovascular Catheters
Specialty / Other Catheters
By End User Hospitals
Ambulatory Surgical Centres
Home-care Settings
Others
By Application Cardiovascular Procedures
Urinary Incontinence & Retention
Dialysis & Renal Disorders
Others
By Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa GCC
South Africa
Rest of Middle East & Africa
South America Brazil
Argentina
Rest of South America
By Product
Cardiovascular Catheters
Urology Catheters
Intravenous Catheters
Neurovascular Catheters
Specialty / Other Catheters
By End User
Hospitals
Ambulatory Surgical Centres
Home-care Settings
Others
By Application
Cardiovascular Procedures
Urinary Incontinence & Retention
Dialysis & Renal Disorders
Others
By Geography
North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa GCC
South Africa
Rest of Middle East & Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

What is the current Global Catheters Market size?

The catheters market was valued at USD 62.0 billion in 2025 and is projected to reach USD 85.2 billion by 2030.

Who are the key players in Global Catheters Market?

Hollister, Medtronic Plc, Coloplast, Becton, Dickinson and Company and B. Braun Melsungen AG are the major companies operating in the Global Catheters Market.

Which is the fastest growing region in Global Catheters Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which product segment leads the catheters market?

Cardiovascular catheters hold the top spot, representing 28.7% of global revenue in 2024.

Page last updated on: June 23, 2025

Global Catheters Market Report Snapshots